Résumé
Les coûts économiques du surpoids et de l’obésité peuvent être évalués par deux approches différentes. L’approche dite du « coût de la maladie », la plus développée, donne une traduction économique de l’ampleur des problèmes posés par une affection donnée. Deux études suggèrent qu’en France le coût médical de l’obésité représente environ 1 % à 2 % des dépenses de santé. La méthodologie utilisée permet probablement d’expliquer ces résultats, relativement bas par rapport à ceux calculés pour d’autres pays (2 % à 7 %). L’approche économique (études coût-efficacité, coût-bénéfice...) permet d’envisager l’intérêt des stratégies en fonction de leur coût, du contexte (âge, comorbidités) et des résultats. Les études sont encore rares dans le domaine de l’obésité.
Abstract
The economic costs of overweight and obesity can be assessed using two different approaches. The cost of illness approach is the most widely developed and produces an economic assessment of the breadth of the problems arising from a given disorder. Two studies suggest that, in France, the medical cost of obesity represents around 1 % to 2 % of all health costs. The reason for these relatively low figures, compared with those in other countries (2 % to 7 %), probably lies in the methodology used. The second approach, the economic approach (which includes cost-effectiveness and cost-benefit analyses), takes into account the benefits of various strategies relative to their cost, context (age and comorbidities) and outcome. At present, there are very few studies of obesity.
Références
Martin Lf, Robinson A, Moore Bj (2000) Socioeconomic issues affecting the treatment of obesity in the new millennium. Pharmacoeconomics 18: 335–353
Avenell A, Broom J, Brown Tj, et al. (2004) Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 8: 1–182
Levy E, Levy P, Le Pen C, et al. (1995) The economic cost of obesity: the French situation. Int J Obes Relat Metab Disord 19: 788–792
Detournay B, Fagnani F, Phillippo M, et al. (2000) Obesity morbidity and health care costs in France: an analysis of the 1991–1992 Medical Care Household Survey. Int J Obes Relat Metab Disord 24: 151–155
OMS (2002) The World Health Report. Reducing risks, promoting healthy life, WHO
Gold Mr, Stevenson D, Fryback Dg (2002) HALYS and QALYS and DALYS, Oh My: similarities and differences in summary measures of population Health. Annu Rev Public Health 23: 115–134
Wylie-Rosett J, Swencionis C, Ginsberg M, et al. (2001) Computerized weight loss intervention optimizes staff time: the clinical and cost results of a controlled clinical trial conducted in a managed care setting. J Am Diet Assoc 101: 1155–1162, quiz 1163–4
Dzator Ja, Hendrie D, Burke V, et al. (2004) A randomized trial of interactive group sessions achieved greater improvements in nutrition and physical activity at a tiny increase in cost. J Clin Epidemiol 57: 610–619
Oster G, Thompson D, Edelsberg J, et al. (1999) Lifetime health and economic benefits of weight loss among obese persons. Am J Public Health 89: 1536–1542
Author information
Consortia
Rights and permissions
About this article
Cite this article
Groupe d’expertise collective de l’Inserm. Coût de la maladie. Obes 2, 48–52 (2007). https://doi.org/10.1007/s11690-007-0032-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11690-007-0032-1